About DotLab
DotLab is a company based in Branford (United States) founded in 2016 by Heather Bowerman. DotLab has raised $10 million across 2 funding rounds from investors including Wilson Sonsini Goodrich & Rosati, HHS and CooperSurgical. The company has 11 employees as of December 31, 2021. DotLab offers products and services including DotEndo. DotLab operates in a competitive market with competitors including Miroculus, Mirvie, Epic Sciences, OncoCyte and Celsee Diagnostics, among others.
- Headquarter Branford, United States
- Employees 11 as on 31 Dec, 2021
- Founders Heather Bowerman
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dot Laboratories, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Series A
Jul 01, 2019
-
Investors
Wilson Sonsini Goodrich & Rosati
& 4 more
-
Employee Count
11
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DotLab
DotLab offers a comprehensive portfolio of products and services, including DotEndo.
Non-invasive blood test for detecting endometriosis biomarkers early.
People of DotLab
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of DotLab
DotLab has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DotLab
DotLab has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati, HHS and CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture and private equity investments are managed with global diversification.
|
Locked | Locked | Locked | |
|
Offers medical devices for fertility, contraception, and women's health care globally.
|
Locked | Locked | Locked | |
|
Provides investment management and capital services for clients.
|
Locked | Locked | Locked |
Investor details for DotLab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DotLab
Investment portfolio details for DotLab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DotLab
Detailed financials for DotLab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dotlab Comparisons
Peer comparison for DotLab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DotLab
DotLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miroculus, Mirvie, Epic Sciences, OncoCyte and Celsee Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| Locked | Locked | Locked |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| Locked | Locked | Locked |
Non-invasive tests for detecting circulating tumor cells are provided.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Liquid biopsy technology for monitoring circulating tumor cells is provided.
|
Detailed competitors of DotLab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dotlab
Complete news archive for DotLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DotLab
DotLab was founded in 2016 and raised its 1st funding round 3 years after it was founded.
DotLab is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.
Heather Bowerman is the current CEO of DotLab. They have also founded this company.
DotLab is a funded company, having raised a total of $10M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at DotLab is 11.
DotLab was founded in 2016 in Branford, United States, and operates in the medical diagnostics sector. A saliva-based liquid biopsy test, known as DotEndo, has been developed to detect specific miRNAs for early identification of endometriosis, avoiding invasive procedures like laparoscopy. The test is prescribed by physicians, who collect samples and forward them to the companys CLIA- and CAP-certified laboratory for analysis.
DotLab offers DotEndo.
DotLab has 5 investors. Key investors include Wilson Sonsini Goodrich & Rosati, HHS, CooperSurgical, Tiger Global, and Luxor Capital Group.